What are the major opportunities in the Chronic Myeloid Leukemia Treatment market? What are the strategies for the Chronic Myeloid Leukemia Treatment market?

For detailed insights on the major opportunities and strategies in the Chronic Myeloid Leukemia Treatment market, Read More

How does the Chronic Myeloid Leukemia Treatment market relate to the overall economy and other similar markets?

For detailed insights on Chronic Myeloid Leukemia Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Chronic Myeloid Leukemia Treatment market growth? SWOT analysis of the Chronic Myeloid Leukemia Treatment market.

For detailed insights on the key dynamics influencing the Chronic Myeloid Leukemia Treatment market growth and SWOT analysis of the Chronic Myeloid Leukemia Treatment industry, Read More

Global Chronic Myeloid Leukemia Treatment Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report

Chronic Myeloid Leukemia Treatment Global Market Report 2025

Name: Chronic Myeloid Leukemia Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Chronic Myeloid Leukemia Treatment Market?

Chronic myeloid leukemia (CML) is a type of cancer that affects the bone marrow and blood cells and is characterized by the overproduction of abnormal white blood cells known as granulocytes. Chronic myeloid leukemia (CML) treatment aims to control the disease, reduce symptoms and improve the quality of life for patients suffering from the disease.

The main types of chronic myeloid leukemia treatment are targeted therapy, chemotherapy, radiation therapy, splenectomy and stem cell transplant. Targeted therapy is a type of cancer treatment that focuses on specific molecules or pathways involved in the growth and survival of cancer cells. The various route of administration includes oral, parenteral and others. These are used by various end-users such as hospitals, specialty clinics and others.

Chronic Myeloid Leukemia Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Chronic Myeloid Leukemia Treatment Market Size 2025 And Growth Rate?

The chronic myeloid leukemia treatment market size has grown strongly in recent years. It will grow from $9.2 billion in 2024 to $9.76 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of chronic myeloid leukemia, growing awareness about cancer treatment, government initiatives, growing research and development activities for chronic myeloid leukemia treatments.

What Is The Chronic Myeloid Leukemia Treatment Market Growth Forecast?

The chronic myeloid leukemia treatment market size is expected to see strong growth in the next few years. It will grow to $13.12 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for effective and more tolerable treatments, rising healthcare spending, investments in chronic myeloid leukemia treatments, growing personalized medicine. Major trends in the forecast period include improved diagnosis and screening, innovative treatments for chronic myeloid leukemia, development of targeted therapies, advanced early diagnosis and screening, monitoring technologies.

Book your 30 minutes free consultation with our research experts

How Is The Chronic Myeloid Leukemia Treatment Market Segmented?

The chronic myeloid leukemia treatment market covered in this report is segmented –

1) By Type: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations

3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Monoclonal Antibodies

2) By Chemotherapy: Combination Chemotherapy, Single-Agent Chemotherapy

3) By Radiation Therapy: External Beam Radiation Therapy, Total Body Irradiation

4) By Splenectomy: Open Splenectomy, Laparoscopic Splenectomy

5) By Stem Cell Transplant: Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant

What Is Driving The Chronic Myeloid Leukemia Treatment Market? Rising Incidences Of Myeloid Leukemia Fuel Growth In The Chronic Myeloid Leukemia (CML) Treatment Market

The increasing incidences of myeloid leukemia are expected to propel the growth of the chronic myeloid leukemia (CML) treatment market going forward. Myeloid leukemia is a type of cancer that originates in the bone marrow and affects the cells responsible for producing various kinds of blood cells. Chronic myeloid leukemia (CML) treatment aims to improve bone marrow function by targeting the root cause of leukemia to reduce the risk of complications with low blood cell counts, reduce the need for chemotherapy and transplants and improve the survival rates for people with myeloid leukemia. For instance, in January 2023, according to the estimates of the American Cancer Society, a US-based voluntary health organization, there were about 20,380 cases and 11,310 deaths of acute myeloid leukemia (AML) in adults in 2023. Therefore, the increasing incidences of myeloid leukemia drive the chronic myeloid leukemia (CML) treatment market.

What Is Driving The Chronic Myeloid Leukemia Treatment Market? Chromosome Abnormalities As Catalysts For Growth In The Chronic Myeloid Leukemia (CML) Treatment Market

The rising incidence of chromosome abnormalities is anticipated to drive the expansion of the chronic myeloid leukemia (CML) treatment market in the future. Chromosome abnormalities refer to structural or numerical anomalies in an individual's chromosomes, which are thread-like structures within cells that carry genetic information. Patients with specific chromosomal abnormalities may have a poor prognosis and necessitate more intensive treatment, such as CML. For instance, according to the National Library of Medicine (NLM), a US-based biomedical informatics and computational health data science research, based on a study conducted in Saudi Arabia, chromosome abnormalities were found in 59 newborn infants with congenital anomalies (39.3%) accounting for 2.3% of total NICU admissions. Hence, the increasing prevalence of chromosome abnormalities is propelling the expansion of the chronic myeloid leukemia (CML) treatment market.

Who Are The Major Players In The Global Chronic Myeloid Leukemia Treatment Market?

Major companies operating in the chronic myeloid leukemia treatment market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Merck and Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Otsuka Holdings Co Ltd., Mylan N.V., Astellas Pharma Inc., Incyte Corporation, Lupin Limited, Seattle Genetics Inc., Innovent Biologics Inc., Xencor Inc., ARIAD Pharmaceuticals Inc., Celon Laboratories Pvt. Ltd.

What Are The Key Trends Of The Global Chronic Myeloid Leukemia Treatment Market? Innovative Diagnostic Solutions Shape The Landscape Of Chronic Myeloid Leukemia (CML) Treatment

Major companies operating in the chronic myeloid leukemia (CML) treatment market are focused on developing innovative products to sustain their position in the market. For instance, in August 2023, Precipio, Inc., a US-based diagnostics company offering cancer diagnosis, launched the BCR-ABL 2.0 Panel for chronic myeloid leukemia (CML). This tool identifies the BCR-ABL1 gene and helps diagnose chronic myeloid leukemia (CML). This is the most advanced BCR-ABL panel with robust coverage, workflow ease and reduced cost with enhanced patient care. Additionally, IT features the detection of the ABL1 mutation, which eliminates the need for a second round of testing for the BCR-ABL1 gene, providing high-accuracy results.

Need data on a specific region in this market?

Request Customisation

What Are Latest Mergers And Acquisitions In The Chronic Myeloid Leukemia Treatment Market? Merck Enhances Oncology Portfolio With Acquisition Of Imago BioSciences

In November 2022, Merck and Co. Inc., a US-based multinational pharmaceutical company, acquired Imago BioSciences for $1.35 billion. The acquisition strengthens Merck's ability to develop innovative therapies for hematologic malignancies, positioning the company to address unmet medical needs in cancer treatment and promoting growth in a competitive market while enhancing patient care initiatives. Imago BioSciences Inc. is a US-based clinical-stage biopharmaceutical company focused on developing innovative treatments for myeloproliferative neoplasms and other bone marrow diseases, including chronic myelogenous leukemia, polycythemia vera, and essential thrombocythemia.

Regional Outlook For The Global Chronic Myeloid Leukemia Treatment Market

North America was the largest region in the chronic myeloid leukemia treatment market in 2024. The regions covered in chronic myeloid leukemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic myeloid leukemia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Myeloid Leukemia Treatment Market?

The chronic myeloid leukemia treatment market consists of revenues earned by entities by providing diagnosis and staging, medical consultations and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic myeloid leukemia (CML) market also includes sales of imatinib, dasatinib, bosutinib and ponatinib. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Chronic Myeloid Leukemia Treatment Industry?

The chronic myeloid leukemia treatment market research report is one of a series of new reports from The Business Research Company that provides chronic myeloid leukemia treatment market statistics, including chronic myeloid leukemia treatment industry global market size, regional shares, competitors with a chronic myeloid leukemia treatment market share, detailed chronic myeloid leukemia treatment market segments, market trends and opportunities and any further data you may need to thrive in the chronic myeloid leukemia treatment industry. This chronic myeloid leukemia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chronic Myeloid Leukemia Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.76 billion
Revenue Forecast In 2034	$13.12 billion
Growth Rate	CAGR of 7.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant 2) By Route of Administration: Oral, Parenteral, Other Route of Administrations 3) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegments: 1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Monoclonal Antibodies 2) By Chemotherapy: Combination Chemotherapy, Single-Agent Chemotherapy 3) By Radiation Therapy: External Beam Radiation Therapy, Total Body Irradiation 4) By Splenectomy: Open Splenectomy, Laparoscopic Splenectomy 5) By Stem Cell Transplant: Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Merck and Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, GSK Plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc, Otsuka Holdings Co Ltd., Mylan N.V., Astellas Pharma Inc., Incyte Corporation, Lupin Limited, Seattle Genetics Inc., Innovent Biologics Inc., Xencor Inc., ARIAD Pharmaceuticals Inc., Celon Laboratories Pvt. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Chronic Myeloid Leukemia Treatment Market Characteristics

3. Chronic Myeloid Leukemia Treatment Market Trends And Strategies

4. Chronic Myeloid Leukemia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Chronic Myeloid Leukemia Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Myeloid Leukemia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Chronic Myeloid Leukemia Treatment Market Growth Rate Analysis

5.4. Global Chronic Myeloid Leukemia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Chronic Myeloid Leukemia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Chronic Myeloid Leukemia Treatment Total Addressable Market (TAM)

6. Chronic Myeloid Leukemia Treatment Market Segmentation

6.1. Global Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Therapy

Chemotherapy

Radiation Therapy

Splenectomy

Stem Cell Transplant

6.2. Global Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route of Administrations

6.3. Global Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Other End-Users

6.4. Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors (TKIs)

Monoclonal Antibodies

6.5. Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Chemotherapy

Single-Agent Chemotherapy

6.6. Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

External Beam Radiation Therapy

Total Body Irradiation

6.7. Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Splenectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Open Splenectomy

Laparoscopic Splenectomy

6.8. Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Autologous Stem Cell Transplant

Allogeneic Stem Cell Transplant

7. Chronic Myeloid Leukemia Treatment Market Regional And Country Analysis

7.1. Global Chronic Myeloid Leukemia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Chronic Myeloid Leukemia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Myeloid Leukemia Treatment Market

8.1. Asia-Pacific Chronic Myeloid Leukemia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Myeloid Leukemia Treatment Market

9.1. China Chronic Myeloid Leukemia Treatment Market Overview

9.2. China Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Myeloid Leukemia Treatment Market

10.1. India Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Myeloid Leukemia Treatment Market

11.1. Japan Chronic Myeloid Leukemia Treatment Market Overview

11.2. Japan Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Myeloid Leukemia Treatment Market

12.1. Australia Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Myeloid Leukemia Treatment Market

13.1. Indonesia Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Myeloid Leukemia Treatment Market

14.1. South Korea Chronic Myeloid Leukemia Treatment Market Overview

14.2. South Korea Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Myeloid Leukemia Treatment Market

15.1. Western Europe Chronic Myeloid Leukemia Treatment Market Overview

15.2. Western Europe Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Myeloid Leukemia Treatment Market

16.1. UK Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Myeloid Leukemia Treatment Market

17.1. Germany Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Myeloid Leukemia Treatment Market

18.1. France Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Myeloid Leukemia Treatment Market

19.1. Italy Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Myeloid Leukemia Treatment Market

20.1. Spain Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Myeloid Leukemia Treatment Market

21.1. Eastern Europe Chronic Myeloid Leukemia Treatment Market Overview

21.2. Eastern Europe Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Myeloid Leukemia Treatment Market

22.1. Russia Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Myeloid Leukemia Treatment Market

23.1. North America Chronic Myeloid Leukemia Treatment Market Overview

23.2. North America Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Myeloid Leukemia Treatment Market

24.1. USA Chronic Myeloid Leukemia Treatment Market Overview

24.2. USA Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Myeloid Leukemia Treatment Market

25.1. Canada Chronic Myeloid Leukemia Treatment Market Overview

25.2. Canada Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Myeloid Leukemia Treatment Market

26.1. South America Chronic Myeloid Leukemia Treatment Market Overview

26.2. South America Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Myeloid Leukemia Treatment Market

27.1. Brazil Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Myeloid Leukemia Treatment Market

28.1. Middle East Chronic Myeloid Leukemia Treatment Market Overview

28.2. Middle East Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Myeloid Leukemia Treatment Market

29.1. Africa Chronic Myeloid Leukemia Treatment Market Overview

29.2. Africa Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Myeloid Leukemia Treatment Market Competitive Landscape And Company Profiles

30.1. Chronic Myeloid Leukemia Treatment Market Competitive Landscape

30.2. Chronic Myeloid Leukemia Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Myeloid Leukemia Treatment Market Other Major And Innovative Companies

31.1. Merck and Co. Inc.

31.2. Sanofi S.A.

31.3. Bristol-Myers Squibb Company

31.4. AstraZeneca Plc

31.5. GSK Plc

31.6. Takeda Pharmaceutical Company Limited

31.7. Amgen Inc.

31.8. Boehringer Ingelheim International GmbH

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Astellas Pharma Inc

31.11. Otsuka Holdings Co Ltd.

31.12. Mylan N.V.

31.13. Astellas Pharma Inc.

31.14. Incyte Corporation

31.15. Lupin Limited

32. Global Chronic Myeloid Leukemia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Myeloid Leukemia Treatment Market

34. Recent Developments In The Chronic Myeloid Leukemia Treatment Market

35. Chronic Myeloid Leukemia Treatment Market High Potential Countries, Segments and Strategies

35.1 Chronic Myeloid Leukemia Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Chronic Myeloid Leukemia Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Chronic Myeloid Leukemia Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Splenectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Chronic Myeloid Leukemia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Chronic Myeloid Leukemia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Johnson and Johnson Limited Financial Performance

Table 81: F. Hoffmann-La Roche AG Financial Performance

Table 82: AbbVie Inc. Financial Performance

Table 83: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Splenectomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Chronic Myeloid Leukemia Treatment Market, Sub-Segmentation Of Stem Cell Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Chronic Myeloid Leukemia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Chronic Myeloid Leukemia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Chronic Myeloid Leukemia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Chronic Myeloid Leukemia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Chronic Myeloid Leukemia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Johnson and Johnson Limited Financial Performance

Figure 81: F. Hoffmann-La Roche AG Financial Performance

Figure 82: AbbVie Inc. Financial Performance

Figure 83: Novartis AG Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

test...

View Report

Cancer Clinical Decision Tools Global Market Report 2025 – By Type (Risk Assessment Tool (RAT), Qcancer), By End-User (Hospital, Clinics) – Market Size, Trends, And Global Forecast 2025-2034...

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Li...

View Report

Cancer Monoclonal Antibodies Global Market Report 2025 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain...

View Report

Cancer Vaccines Global Market Report 2025 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vac...

View Report

Electrical Safety Personal Protective Equipment Global Market Report 2025 – By Product Type (Head Protection, Eye And Face Protection, Hearing Protection, Protective Footwear, Hand Protection, Arc Rated Clothing), By App...

View Report

Synthetic Aperture Radar Global Market Report 2025 – By Component (Receiver, Transmitter, Antenna), By Platform (Airborne, Ground), By Mode (Single Mode, Multimode), By Frequency Band (X Band, L Band, C Band, S Band, K, ...

View Report

Application Hosting Global Market Report 2025 – By Type (Managed Hosting, Cloud Hosting, Colocation Hosting), By Service (Application Monitoring, Application Programming Interface Management, Infrastructure Services, Dat...

View Report

Frequently Asked Questions

What is the definition of the Chronic Myeloid Leukemia Treatment market?

How will the Chronic Myeloid Leukemia Treatment market drivers and restraints affect the market dynamics? What forces will shape the Chronic Myeloid Leukemia Treatment industry going forward?

The Chronic Myeloid Leukemia Treatment market major growth driver - Rising Incidences Of Myeloid Leukemia Fuel Growth In The Chronic Myeloid Leukemia (CML) Treatment Market. For further insights on the Chronic Myeloid Leukemia Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Chronic Myeloid Leukemia Treatment market?

The Chronic Myeloid Leukemia Treatment market size has grown strongly in recent years. The chronic myeloid leukemia treatment market size has grown strongly in recent years. It will grow from $9.2 billion in 2024 to $9.76 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of chronic myeloid leukemia, growing awareness about cancer treatment, government initiatives, growing research and development activities for chronic myeloid leukemia treatments. The chronic myeloid leukemia treatment market size is expected to see strong growth in the next few years. It will grow to $13.12 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for effective and more tolerable treatments, rising healthcare spending, investments in chronic myeloid leukemia treatments, growing personalized medicine. Major trends in the forecast period include improved diagnosis and screening, innovative treatments for chronic myeloid leukemia, development of targeted therapies, advanced early diagnosis and screening, monitoring technologies. For further insights on the Chronic Myeloid Leukemia Treatment market, request a sample here

How is the Chronic Myeloid Leukemia Treatment market segmented?

The chronic myeloid leukemia treatment market covered in this report is segmented –
1) By Type: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Monoclonal Antibodies
2) By Chemotherapy: Combination Chemotherapy, Single-Agent Chemotherapy
3) By Radiation Therapy: External Beam Radiation Therapy, Total Body Irradiation
4) By Splenectomy: Open Splenectomy, Laparoscopic Splenectomy
5) By Stem Cell Transplant: Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant For further insights on the Chronic Myeloid Leukemia Treatment market, request a sample here

Which region has the largest share of the Chronic Myeloid Leukemia Treatment market? What are the other regions covered in the report?

North America was the largest region in the chronic myeloid leukemia treatment market in 2024. The regions covered in chronic myeloid leukemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the Chronic Myeloid Leukemia Treatment market, request a sample here.

Who are the major players in the Chronic Myeloid Leukemia Treatment market?

What are the key trends in the Chronic Myeloid Leukemia Treatment market?

Major trends in the Chronic Myeloid Leukemia Treatment market include Innovative Diagnostic Solutions Shape The Landscape Of Chronic Myeloid Leukemia (CML) Treatment. For further insights on the Chronic Myeloid Leukemia Treatment market, request a sample here.

Book your 30 minutes free consultation with our research experts

Chronic Myeloid Leukemia Treatment Global Market Report 2025

By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

What Is Covered Under Chronic Myeloid Leukemia Treatment Market?

What Is The Chronic Myeloid Leukemia Treatment Market Size 2025 And Growth Rate?

What Is The Chronic Myeloid Leukemia Treatment Market Growth Forecast?

How Is The Chronic Myeloid Leukemia Treatment Market Segmented?

What Is Driving The Chronic Myeloid Leukemia Treatment Market? Rising Incidences Of Myeloid Leukemia Fuel Growth In The Chronic Myeloid Leukemia (CML) Treatment Market

What Is Driving The Chronic Myeloid Leukemia Treatment Market? Chromosome Abnormalities As Catalysts For Growth In The Chronic Myeloid Leukemia (CML) Treatment Market

Who Are The Major Players In The Global Chronic Myeloid Leukemia Treatment Market?

What Are The Key Trends Of The Global Chronic Myeloid Leukemia Treatment Market? Innovative Diagnostic Solutions Shape The Landscape Of Chronic Myeloid Leukemia (CML) Treatment

What Are Latest Mergers And Acquisitions In The Chronic Myeloid Leukemia Treatment Market? Merck Enhances Oncology Portfolio With Acquisition Of Imago BioSciences

Regional Outlook For The Global Chronic Myeloid Leukemia Treatment Market

What Defines the Chronic Myeloid Leukemia Treatment Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Chronic Myeloid Leukemia Treatment Industry?

Chronic Myeloid Leukemia Treatment Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions